CDIO Cardio Diagnostics Holdings: שווי פעילות לרווח לפני ריבית, מסים ופחת
The daily price chart for Cardio Diagnostics (CDIO) shows an EV/EBITDA ratio of 0.00. Cardio Diagnostics is integrating environmental standards into genetic diagnostics by minimizing emissions and digitizing reporting. The business is shielded from external political shocks, as it operates exclusively within the US. Revenue is generated through the sale of epigenetic tests to clinics specializing in the early detection of cardiovascular pathologies.
פילוחי נתונים אנליטיים מרוכזים עבור cardiodiagnosticsinc.com (CDIO)
Cardio Diagnostics (CDIO) is scaling the implementation of AI tests for ischemia diagnostics, creating a stable B2B revenue stream. The company's EV/EBITDA multiple compares the total enterprise value, including debt, with its operating profit before taxes and amortization. Analyzing this curve allows for an assessment of asset capitalization efficiency and cash flow sustainability under conditions of high leverage.
